The chairman was particularly vague on this always stating 2016 and not being specific as to when in 2016.. You have to remember the clinical trial is being conducted by a independent 3rd party so ALT have no say or influence over the trial, recruitment process or end date.. I got from the AGM that the initial trial is around efficacy of the product however there seems to be a 2nd end point for sexual dysfunction which may be closer to end of 2016...
Also a very interesting point made was that the baseline or control group in the CT is a group of women who instead of using the pericoach are getting specific individual supervised training on PFE monitored directly by a specialist clinician and that group then have monthly meetings with the clinician to ensure PFE are being done correctly. So the Pericoach results will be measured against that control group -
ALT Price at posting:
0.6¢ Sentiment: Hold Disclosure: Held